Dr Reddy’s Labs: New launch booster

Dr Reddy’s Laboratories, after market hours on Tuesday, informed the exchanges that it has launched Sirolimus tablet variants (1 mg and 2 mg) in the US. Sirolimus is used to prevent rejection in organ transplants; it is especially useful in kidney transplants. According to the company, its equivalent Rapamune brand for the year ended August recorded sales of $206 million in the US markets. On October 27, the company received US FDA nod for marketing the product.